AGP Executive Report
Last update: 8 hours agoVaccine Trial: Danish researchers are defending a revised hepatitis B study involving 14,000 newborns, but Guinea-Bissau’s health minister says the government has not authorized it. Ethics approval does not amount to national permission; the proposed trial would delay the birth dose for half the babies until six weeks. Seismic Technology: TGS and state oil company PetroGuin will reprocess more than 11,000 km² of offshore 3D seismic data using advanced imaging methods. Work is due to start in late 2026, with results expected in 2027. Cloud Collaboration: Guinea-Bissau specialists joined more than 30 experts at Orange Cameroun’s Telco Cloud Workshop, which focused on developing the company’s cloud platform. Regional Connectivity: Guinea says AfDB-backed road projects linking it with Guinea-Bissau and Sierra Leone are helping turn AfCFTA ambitions into practical cross-border trade links.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
